Latest Period
n/a
Security Snapshot
QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN) Institutional Ownership
CUSIP: 74754R103
13F Institutional Holders and Ownership History from Q2 2020 to Q4 2022
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- QLGN on Nasdaq
- Shares outstanding
- 6,138,804
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share is tracked under CUSIP 74754R103.
- Latest finished 13F holder period is not available.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 22 to 0 between Q3 2022 and Q4 2022.
- Reported value moved from $619,043 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Investment Quick Answers
What is CUSIP 74754R103?
CUSIP 74754R103 identifies QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74754R103:
Significant Owners of QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FARADAY FUTURE INTELLIGENT ELECTRIC INC. | 20% | +150% | 1,227,147 | +393% | FARADAY FUTURE INTELLIGENT ELECTRIC INC. | 17 Nov 2025 | ||
| ALPHA CAPITAL ANSTALT | 2.2% | 36,434 | Alpha Capital Anstalt | 21 Jul 2025 |
Institutional Holders of QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2022 Q4 | 0 | $0 | -$619,043 | 0 | |
| 2022 Q3 | 2,314,772 | $619,043 | -$2,104 | $0.27 | 22 |
| 2022 Q2 | 2,274,870 | $1,294,095 | -$331,488 | $0.57 | 23 |
| 2022 Q1 | 2,808,708 | $1,851,111 | -$24,255 | $0.66 | 28 |
| 2021 Q4 | 2,669,299 | $2,854,181 | -$109,633 | $1.07 | 25 |
| 2021 Q3 | 2,777,239 | $3,612,208 | +$302,490 | $1.30 | 26 |
| 2021 Q2 | 2,534,130 | $5,043,318 | +$1,183,860 | $1.99 | 27 |
| 2021 Q1 | 1,892,924 | $5,108,432 | +$1,699,282 | $2.70 | 28 |
| 2020 Q4 | 1,190,365 | $3,582,482 | +$1,037,310 | $3.01 | 25 |
| 2020 Q3 | 810,100 | $4,010,792 | +$3,531,748 | $4.95 | 15 |
| 2020 Q2 | 110,857 | $440,635 | +$440,635 | $3.97 | 8 |